Pay in 4 interest-free payments of $5.58 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
The Science Supporting Our Approach Our protocols are directly informed by the latest clinical research, including the groundbreaking 2025 Galderma study that specifically examined facial volume loss in patients using GLP-1 medications
Results : Significant visceral fat reduction Lean muscle preservation/gain Improved lipid profiles Enhanced body composition Strong anti-aging effects Pros : FDA-approved Highly effective Targets visceral fat specifically Well-studied safety profile Medical legitimacy Cons : Pharmaceutical version extremely expensive Requires prescription (specific indication) Daily injection required Research version only affordable option for most Who it's for : People with significant visceral fat
Key takeaways When Ozempic is covered by insurance, its typically for Type 2 diabetes management, not weight loss
These findings were presented at the CHEST Annual Meeting 2025
US$ 22.09
US$ 21.04
US$ 27.51
US$ 28.79
US$ 25.79
